首页 > 最新文献

Infection and Chemotherapy最新文献

英文 中文
Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study. 在开始一线抗逆转录病毒疗法的新感染 HIV-1 患者中,细胞减少的发生率及其与免疫抑制的相关性:一项试点研究。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-12-01 DOI: 10.3947/ic.2023.0080
Abdulrasheed Usman, Olayemi Balogun, Bukhari Isah Shuaib, Bolanle O P Musa, Aminu Abba Yusuf, Ebenezer I O Ajayi

Background: Cytopenias serve as common indicators and crucial predictive tools for evaluating disease progression and therapeutic outcomes in individuals with human immunodeficiency virus (HIV) infection. This study aimed to assess the prevalence of cytopenias and their correlation with the level of immunosuppression in treatment-naive HIV-infected participants after initiating highly active combined antiretroviral drug therapy (cART24).

Materials and methods: This prospective study focused on evaluating cytopenia in 44 treatment-naive HIV-infected patients who consented to initiate cART and were consecutively enrolled. The research was conducted at the Nasara HIV Treatment & Care Centre of Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria, spanning from December 2016 to January 2018. Cytopenias, including anemia, leucopenia, lymphocytopenia, and thrombocytopenia, were defined and assessed according to World Health Organization guidelines. A combination of cross-sectional and longitudinal mixed-design two-step analysis was employed to validate our findings.

Results: The median time from enrollment to cART initiation was 7 days, following the universal test and treat protocol. The prevalence of cytopenia was 75% at the baseline before treatment and increased to 84% after cART24 administration. There were no statistically significant differences in the median values of immuno-hematological parameters between baseline and after cART24 initiation (P >0.05). In terms of longitudinal assessment, the prevalence of anemia, leucopenia, lymphopenia, and thrombocytopenia at baseline were 66%, 23%, 0%, and 11%, respectively, and after cART24, the rates were 66%, 29%, 5%, and 20%. Notably, the prevalence of cytopenia correlated with declining CD4+ T cell counts. Among instances of unicytopenia, 58% exhibited isolated anemia, 6% had lone leucopenia, and 6% had solitary thrombocytopenia. Additionally, 27% demonstrated bi-cytopenia, and 3% exhibited pancytopenia. Interestingly, none of the study participants presented with lymphopenia. The most common combination was anemia and thrombocytopenia. Both longitudinal and cross-sectional analytical findings were consistent.

Conclusion: In treatment-naive HIV-infected individuals, the prevalence of cytopenias, particularly anemia and thrombocytopenia, was substantial and correlated with the degree of immunosuppression as indicated by CD4+ T cell counts. These cytopenias persisted despite initiation of cART24, highlighting the complexity of hematological manifestations in HIV infection. Our study underscores the significant hematopathological impact of HIV and antiretroviral therapy, highlighting the necessity for preventive strategies to mitigate these adverse effects.

背景:细胞减少症是评估人类免疫缺陷病毒(HIV)感染者疾病进展和治疗效果的常见指标和重要预测工具。本研究旨在评估细胞减少症的发生率及其与开始接受高活性联合抗逆转录病毒药物治疗(cART24)后的免疫抑制水平的相关性:这项前瞻性研究的重点是评估 44 名同意开始 cART 并连续入组的接受治疗的艾滋病病毒感染者的全血细胞减少症。研究于 2016 年 12 月至 2018 年 1 月在尼日利亚扎里亚艾哈迈杜-贝洛大学教学医院(ABUTH)的 Nasara HIV 治疗&护理中心进行。细胞减少症包括贫血、白细胞减少症、淋巴细胞减少症和血小板减少症,根据世界卫生组织指南进行定义和评估。我们采用了横向和纵向混合设计的两步分析法来验证我们的研究结果:按照普遍的检测和治疗方案,从入院到开始接受 cART 治疗的中位时间为 7 天。在治疗前的基线期,全血细胞减少率为 75%,而在使用 cART24 后,全血细胞减少率增至 84%。免疫血液学参数的中位值在基线和开始使用 cART24 后没有明显的统计学差异(P>0.05)。在纵向评估方面,基线时贫血、白细胞减少症、淋巴细胞减少症和血小板减少症的发生率分别为66%、23%、0%和11%,而在使用cART24后,发生率分别为66%、29%、5%和20%。值得注意的是,全血细胞减少的发生率与 CD4+ T 细胞计数的下降有关。在单核细胞减少的病例中,58%表现为孤立性贫血,6%为孤立性白细胞减少,6%为孤立性血小板减少。此外,有 27% 的人表现为全血细胞减少,3% 的人表现为泛血细胞减少。有趣的是,研究参与者中没有一人出现淋巴细胞减少症。最常见的合并症是贫血和血小板减少。纵向和横向分析结果一致:在接受过治疗的艾滋病病毒感染者中,细胞减少症,尤其是贫血和血小板减少症的发病率很高,并且与 CD4+ T 细胞计数显示的免疫抑制程度相关。尽管开始接受 cART24 治疗,但这些细胞减少症依然存在,这凸显了 HIV 感染者血液学表现的复杂性。我们的研究强调了艾滋病毒和抗逆转录病毒疗法对血液病理学的重大影响,突出了采取预防策略减轻这些不良影响的必要性。
{"title":"Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study.","authors":"Abdulrasheed Usman, Olayemi Balogun, Bukhari Isah Shuaib, Bolanle O P Musa, Aminu Abba Yusuf, Ebenezer I O Ajayi","doi":"10.3947/ic.2023.0080","DOIUrl":"10.3947/ic.2023.0080","url":null,"abstract":"<p><strong>Background: </strong>Cytopenias serve as common indicators and crucial predictive tools for evaluating disease progression and therapeutic outcomes in individuals with human immunodeficiency virus (HIV) infection. This study aimed to assess the prevalence of cytopenias and their correlation with the level of immunosuppression in treatment-naive HIV-infected participants after initiating highly active combined antiretroviral drug therapy (cART24).</p><p><strong>Materials and methods: </strong>This prospective study focused on evaluating cytopenia in 44 treatment-naive HIV-infected patients who consented to initiate cART and were consecutively enrolled. The research was conducted at the Nasara HIV Treatment &amp; Care Centre of Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria, spanning from December 2016 to January 2018. Cytopenias, including anemia, leucopenia, lymphocytopenia, and thrombocytopenia, were defined and assessed according to World Health Organization guidelines. A combination of cross-sectional and longitudinal mixed-design two-step analysis was employed to validate our findings.</p><p><strong>Results: </strong>The median time from enrollment to cART initiation was 7 days, following the universal test and treat protocol. The prevalence of cytopenia was 75% at the baseline before treatment and increased to 84% after cART24 administration. There were no statistically significant differences in the median values of immuno-hematological parameters between baseline and after cART24 initiation (<i>P</i> >0.05). In terms of longitudinal assessment, the prevalence of anemia, leucopenia, lymphopenia, and thrombocytopenia at baseline were 66%, 23%, 0%, and 11%, respectively, and after cART24, the rates were 66%, 29%, 5%, and 20%. Notably, the prevalence of cytopenia correlated with declining CD4+ T cell counts. Among instances of unicytopenia, 58% exhibited isolated anemia, 6% had lone leucopenia, and 6% had solitary thrombocytopenia. Additionally, 27% demonstrated bi-cytopenia, and 3% exhibited pancytopenia. Interestingly, none of the study participants presented with lymphopenia. The most common combination was anemia and thrombocytopenia. Both longitudinal and cross-sectional analytical findings were consistent.</p><p><strong>Conclusion: </strong>In treatment-naive HIV-infected individuals, the prevalence of cytopenias, particularly anemia and thrombocytopenia, was substantial and correlated with the degree of immunosuppression as indicated by CD4+ T cell counts. These cytopenias persisted despite initiation of cART24, highlighting the complexity of hematological manifestations in HIV infection. Our study underscores the significant hematopathological impact of HIV and antiretroviral therapy, highlighting the necessity for preventive strategies to mitigate these adverse effects.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"55 4","pages":"479-489"},"PeriodicalIF":4.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139111350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severity of COVID-19 Pneumonia in Kidney Transplant Recipients According to SARS-CoV-2 Vaccination. 肾移植受者 COVID-19 肺炎的严重程度与 SARS-CoV-2 疫苗接种有关。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-12-01 DOI: 10.3947/ic.2023.0083
Seunghyeok Choi, Hanbi Lee, Sang Hun Eum, Ji-Won Min, Hye Eun Yoon, Chul Woo Yang, Byung Ha Chung

We reviewed 24 kidney transplantat recipients (KTRs) who had radiologically confirmed coronavirus disease 2019 (COVID-19) pneumonia. Enrolled KTRs were divided into a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-vaccination (+) group (n = 18) and a vaccination (-) group (n = 6). Clinical outcomes of the two groups including death, pulmonary outcome, and renal outcome were compared. COVID-19 pneumonia was worse in vaccination (-) KTRs. Two out of six vaccination (-) KTRs needed continuous renal replacement therapy (CRRT) and mechanical ventilator (MV) and expired. In contrast, only one KTR expired and required CRRT and MV out of 18 vaccination (+) KTRs. Our results suggest that SARS-CoV-2 vaccination attenuates severity of COVID-19 pneumonia in KTRs.

我们对 24 例经放射学证实患有 2019 年冠状病毒病(COVID-19)肺炎的肾移植受者(KTR)进行了回顾性研究。入组的 KTR 被分为严重急性呼吸系统综合征冠状病毒 2 (SARS-CoV-2) 疫苗接种 (+) 组(18 人)和疫苗接种 (-) 组(6 人)。比较了两组的临床结果,包括死亡、肺部结果和肾脏结果。接种疫苗(-)的 KTR 患 COVID-19 肺炎的情况更严重。六名接种疫苗(-)的 KTR 中,有两人需要持续肾脏替代疗法 (CRRT) 和机械呼吸机 (MV),并最终死亡。相比之下,在 18 例接种疫苗(+)的 KTR 中,只有 1 例 KTR 死亡并需要接受 CRRT 和 MV 治疗。我们的研究结果表明,接种 SARS-CoV-2 疫苗可减轻 KTR 患者 COVID-19 肺炎的严重程度。
{"title":"Severity of COVID-19 Pneumonia in Kidney Transplant Recipients According to SARS-CoV-2 Vaccination.","authors":"Seunghyeok Choi, Hanbi Lee, Sang Hun Eum, Ji-Won Min, Hye Eun Yoon, Chul Woo Yang, Byung Ha Chung","doi":"10.3947/ic.2023.0083","DOIUrl":"10.3947/ic.2023.0083","url":null,"abstract":"<p><p>We reviewed 24 kidney transplantat recipients (KTRs) who had radiologically confirmed coronavirus disease 2019 (COVID-19) pneumonia. Enrolled KTRs were divided into a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-vaccination (+) group (n = 18) and a vaccination (-) group (n = 6). Clinical outcomes of the two groups including death, pulmonary outcome, and renal outcome were compared. COVID-19 pneumonia was worse in vaccination (-) KTRs. Two out of six vaccination (-) KTRs needed continuous renal replacement therapy (CRRT) and mechanical ventilator (MV) and expired. In contrast, only one KTR expired and required CRRT and MV out of 18 vaccination (+) KTRs. Our results suggest that SARS-CoV-2 vaccination attenuates severity of COVID-19 pneumonia in KTRs.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"55 4","pages":"505-509"},"PeriodicalIF":4.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139111356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Nocardiosis: a Multicenter Retrospective Study in Korea. 诺卡氏菌病的临床特征:韩国一项多中心回顾性研究。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-12-01 Epub Date: 2023-08-04 DOI: 10.3947/ic.2023.0032
Seulki Kim, Hye Jin Shi, Cheon-Hoo Jeon, Sun Bean Kim, Jongyoun Yi, A Reum Kim, Kye-Hyung Kim, Seungjin Lim

Background: Nocardiosis is a rare, but potentially life-threatening condition. It is difficult to diagnose, and bacterial culture identification can be time consuming. We investigated the characteristics of nocardiosis and the suitability of the treatment approach in Korea.

Materials and methods: This retrospective study was conducted at 5 medical institutions between 2011 and 2021. We reviewed the medical records of patients with microbiologically confirmed nocardiosis. Appropriate antibiotic selection was defined as follows: (1) selecting antibiotics according to the species, (2) if the species of Nocardia was unknown, trimethoprim-sulfamethoxazole-based therapy or linezolid-based therapy was administered, and (3) selection of antibiotics using the antibiotic susceptibility test. The appropriate treatment periods for antibiotics were defined as treatment maintained from 3 to 12 months, depending on involvement of the organs. Descriptive analysis and Fisher exact test were used. Statistical significance was set at P-values of <0.05.

Results: Thirty patients were enrolled. Of these patients, 18 (60.0%) were male. The median age was 70.5 years. Among the diagnosed patients, 12 (40.0%) had an immunocompromised status. Eight (30.0%) patients received optimal treatment for the appropriate treatment period. Appropriate dosing duration was observed in 3 of the 12 (25.0%) immunocompromised patients. There was no significant difference between the presence or absence of immunosuppression and the adequacy of treatment for nocardiosis (P = 1.000). Skin and soft tissue (14 patients) were most frequently involved in this study. Nocardia species (spp.) were isolated from culture at a median of 6.0 days. There were 7 cases with N. farcinica (23.3%).

Conclusion: We found that 60.0% of the patients with nocardiosis did not have an immunocompromised status. Further, 26.7% of the total patients received adequate treatment for nocardiosis. The reasons for suboptimal management of nocardiosis in Korea are presumed to be diagnostic difficulties, lack of awareness about nocardiosis, and difficulties in selecting antibiotics for Nocardia spp. among clinicians. The lack of antibiotic susceptibility tests for Nocardia spp. could be the source of these problems. Nocardiosis should be suspected in cases of recurrent infections with skin and soft tissue, musculoskeletal, or respiratory system involvement with or without an immunocompromised status. Clinical microbiological support is required for the diagnosis and selection of antibiotics in Korea. High clinical index of suspicion and clinical microbiological support are required for the accurate diagnosis of nocardiosis in Korea.

背景:诺卡氏杆菌病是一种罕见但可能危及生命的疾病。它很难诊断,细菌培养鉴定也很费时。我们调查了韩国诺卡氏菌病的特点和治疗方法的适用性:这项回顾性研究于 2011 年至 2021 年期间在 5 家医疗机构进行。我们查阅了经微生物学确诊的念珠菌病患者的病历。适当选择抗生素的定义如下:(1)根据菌种选择抗生素;(2)如果诺卡菌菌种不明,则采用三甲双胍-磺胺甲恶唑治疗或利奈唑胺治疗;(3)使用抗生素药敏试验选择抗生素。根据受累器官的不同,抗生素的适当治疗期为 3 至 12 个月。采用描述性分析和费雪精确检验。统计意义以 P 值为标准:共招募了 30 名患者。其中 18 人(60.0%)为男性。年龄中位数为 70.5 岁。在确诊的患者中,12 人(40.0%)免疫力低下。8名患者(30.0%)在适当的治疗期内接受了最佳治疗。在 12 名(25.0%)免疫力低下的患者中,有 3 人(25.0%)接受了适当的用药时间。是否存在免疫抑制与治疗诺卡菌病的充分性之间没有明显差异(P = 1.000)。在本研究中,皮肤和软组织(14 名患者)最常受累。从培养物中分离出诺卡氏菌(属)的时间中位数为 6.0 天。结论:我们发现,60.0%的患者感染了诺卡氏菌(Nocardia):我们发现,60.0%的诺卡菌病患者没有免疫力低下的情况。此外,26.7%的患者接受了适当的诺卡菌病治疗。韩国对诺卡氏菌病的治疗效果不佳的原因被认为是诊断困难、缺乏对诺卡氏菌病的认识,以及临床医生在为诺卡氏菌属选择抗生素时遇到困难。缺乏针对诺卡氏杆菌的抗生素药敏试验可能是这些问题的根源。无论是否存在免疫力低下的情况,如果出现皮肤和软组织、肌肉骨骼或呼吸系统受累的复发性感染,都应怀疑是诺卡氏杆菌病。在韩国,诊断和选择抗生素需要临床微生物学支持。在韩国,准确诊断诺卡菌病需要高度的临床怀疑指数和临床微生物学支持。
{"title":"Clinical Characteristics of Nocardiosis: a Multicenter Retrospective Study in Korea.","authors":"Seulki Kim, Hye Jin Shi, Cheon-Hoo Jeon, Sun Bean Kim, Jongyoun Yi, A Reum Kim, Kye-Hyung Kim, Seungjin Lim","doi":"10.3947/ic.2023.0032","DOIUrl":"10.3947/ic.2023.0032","url":null,"abstract":"<p><strong>Background: </strong>Nocardiosis is a rare, but potentially life-threatening condition. It is difficult to diagnose, and bacterial culture identification can be time consuming. We investigated the characteristics of nocardiosis and the suitability of the treatment approach in Korea.</p><p><strong>Materials and methods: </strong>This retrospective study was conducted at 5 medical institutions between 2011 and 2021. We reviewed the medical records of patients with microbiologically confirmed nocardiosis. Appropriate antibiotic selection was defined as follows: (1) selecting antibiotics according to the species, (2) if the species of <i>Nocardia</i> was unknown, trimethoprim-sulfamethoxazole-based therapy or linezolid-based therapy was administered, and (3) selection of antibiotics using the antibiotic susceptibility test. The appropriate treatment periods for antibiotics were defined as treatment maintained from 3 to 12 months, depending on involvement of the organs. Descriptive analysis and Fisher exact test were used. Statistical significance was set at <i>P</i>-values of <0.05.</p><p><strong>Results: </strong>Thirty patients were enrolled. Of these patients, 18 (60.0%) were male. The median age was 70.5 years. Among the diagnosed patients, 12 (40.0%) had an immunocompromised status. Eight (30.0%) patients received optimal treatment for the appropriate treatment period. Appropriate dosing duration was observed in 3 of the 12 (25.0%) immunocompromised patients. There was no significant difference between the presence or absence of immunosuppression and the adequacy of treatment for nocardiosis (<i>P</i> = 1.000). Skin and soft tissue (14 patients) were most frequently involved in this study. <i>Nocardia</i> species (spp.) were isolated from culture at a median of 6.0 days. There were 7 cases with <i>N. farcinica</i> (23.3%).</p><p><strong>Conclusion: </strong>We found that 60.0% of the patients with nocardiosis did not have an immunocompromised status. Further, 26.7% of the total patients received adequate treatment for nocardiosis. The reasons for suboptimal management of nocardiosis in Korea are presumed to be diagnostic difficulties, lack of awareness about nocardiosis, and difficulties in selecting antibiotics for <i>Nocardia</i> spp. among clinicians. The lack of antibiotic susceptibility tests for <i>Nocardia</i> spp. could be the source of these problems. Nocardiosis should be suspected in cases of recurrent infections with skin and soft tissue, musculoskeletal, or respiratory system involvement with or without an immunocompromised status. Clinical microbiological support is required for the diagnosis and selection of antibiotics in Korea. High clinical index of suspicion and clinical microbiological support are required for the accurate diagnosis of nocardiosis in Korea.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"431-440"},"PeriodicalIF":4.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10169898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First Detection of Enterovirus D68 in Korean Children, September 2022. 2022 年 9 月,首次在韩国儿童中检测到肠道病毒 D68。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-12-01 Epub Date: 2023-07-26 DOI: 10.3947/ic.2023.0036
Ki Wook Yun, Bin Ahn, Sung Hwan Choi, Da Yeon Kang, Taek Soo Kim, Mi Kyung Lee, Kyoung Un Park, Eun Hwa Choi

Background: Enterovirus D68 (EV-D68) is a re-emerging pathogen that is particularly common in children and may cause asthma-like respiratory infection and acute flaccid myelitis. However, in Korea, EV-D68 has never been reported thus far. This study aimed to identify EV-D68 from nasopharyngeal aspirates (NPAs) in Korean children with a respiratory tract infection.

Materials and methods: The EV-D68 reference strain was purchased and blindly used to assess the detection ability of three commercial and one in-house mRT-PCR kit in 2018. Then, we selected children whose specimens were positive for human rhinovirus (HRV) and/or enterovirus (EV) by Allplex mRT-PCR (Seegene, Inc., Seoul, Korea) from April to December 2022. Total RNA was extracted from NPAs, and a partial 5'-UTR gene was amplified and sequenced for the identification of HRV/EV species. Additionally, PCR targeting the VP1 gene was performed to assess EV-D68-positive NPAs, followed by sequencing. Phylogenetic analysis and comparison of amino acid sequence alignments were performed using a partial VP1 gene of our and recent international EV-D68 strains.

Results: Among the mRT-PCR kits tested, only the in-house kit was able to detect EV-D68 in 2018. However, we detected three EV-D68 strains among children hospitalized with fever and/or respiratory symptoms in September - December 2022 who tested positive for EV by the Allplex kit. Two of them were healthy toddlers with lower respiratory infections accompanied by new-onset wheezing but no neurologic complications. Among 34 children with lower respiratory infection who tested positive for HRV during the same period, EV-D68 was not detected. Phylogenetic analysis revealed that the first Korean EV-D68 belonged to subclade B3. Amino acid sequence alignment of international subclade B3 EV-D68 strains also showed that our strain is genetically more related to those from Europe than those from Japan.

Conclusion: We first detected EV-D68 in three Korean children who had EV detected by the Allplex mRT-PCR kit in 2022. EV-D68 also circulated in Korea in fall 2022, but the prevalence and severity seemed to be lower than those in previous reports from other countries.

背景:肠道病毒 D68(EV-D68)是一种重新出现的病原体,尤其常见于儿童,可引起哮喘样呼吸道感染和急性弛缓性脊髓炎。然而,迄今为止,韩国从未报道过 EV-D68。本研究旨在从韩国呼吸道感染儿童的鼻咽吸出物(NPA)中鉴定 EV-D68:2018年,我们购买了EV-D68参考菌株,并盲法评估了三种商用和一种自制mRT-PCR试剂盒的检测能力。然后,我们选择了2022年4月至12月期间用Allplex mRT-PCR(Seegene公司,韩国首尔)检测人类鼻病毒(HRV)和/或肠道病毒(EV)标本呈阳性的儿童。从NPA中提取总RNA,扩增部分5'-UTR基因并进行测序,以确定HRV/EV的种类。此外,还进行了针对 VP1 基因的 PCR,以评估 EV-D68 阳性的 NPA,然后进行测序。利用我国和近期国际 EV-D68 株系的部分 VP1 基因进行了系统发育分析和氨基酸序列比对:在测试的 mRT-PCR 试剂盒中,2018 年只有内部试剂盒能够检测到 EV-D68。然而,我们在2022年9月至12月期间因发烧和/或呼吸道症状住院的儿童中检测到了3株EV-D68菌株,这些儿童经Allplex试剂盒检测后EV呈阳性。其中两名是健康幼儿,他们患有下呼吸道感染并伴有新发喘息,但没有神经系统并发症。同期,34 名下呼吸道感染儿童的 HRV 检测结果呈阳性,其中未检测到 EV-D68。系统发生学分析表明,韩国首例EV-D68属于B3亚支系。国际 B3 亚群 EV-D68 株系的氨基酸序列比对也显示,我们的株系与欧洲株系的基因亲缘关系比日本株系的基因亲缘关系更近:结论:2022 年,我们首次在用 Allplex mRT-PCR 试剂盒检测到 EV 的三名韩国儿童中发现了 EV-D68。2022年秋季,EV-D68也在韩国流行,但其流行率和严重程度似乎低于其他国家的报告。
{"title":"First Detection of Enterovirus D68 in Korean Children, September 2022.","authors":"Ki Wook Yun, Bin Ahn, Sung Hwan Choi, Da Yeon Kang, Taek Soo Kim, Mi Kyung Lee, Kyoung Un Park, Eun Hwa Choi","doi":"10.3947/ic.2023.0036","DOIUrl":"10.3947/ic.2023.0036","url":null,"abstract":"<p><strong>Background: </strong>Enterovirus D68 (EV-D68) is a re-emerging pathogen that is particularly common in children and may cause asthma-like respiratory infection and acute flaccid myelitis. However, in Korea, EV-D68 has never been reported thus far. This study aimed to identify EV-D68 from nasopharyngeal aspirates (NPAs) in Korean children with a respiratory tract infection.</p><p><strong>Materials and methods: </strong>The EV-D68 reference strain was purchased and blindly used to assess the detection ability of three commercial and one in-house mRT-PCR kit in 2018. Then, we selected children whose specimens were positive for human rhinovirus (HRV) and/or enterovirus (EV) by Allplex mRT-PCR (Seegene, Inc., Seoul, Korea) from April to December 2022. Total RNA was extracted from NPAs, and a partial 5'-UTR gene was amplified and sequenced for the identification of HRV/EV species. Additionally, PCR targeting the VP1 gene was performed to assess EV-D68-positive NPAs, followed by sequencing. Phylogenetic analysis and comparison of amino acid sequence alignments were performed using a partial VP1 gene of our and recent international EV-D68 strains.</p><p><strong>Results: </strong>Among the mRT-PCR kits tested, only the in-house kit was able to detect EV-D68 in 2018. However, we detected three EV-D68 strains among children hospitalized with fever and/or respiratory symptoms in September - December 2022 who tested positive for EV by the Allplex kit. Two of them were healthy toddlers with lower respiratory infections accompanied by new-onset wheezing but no neurologic complications. Among 34 children with lower respiratory infection who tested positive for HRV during the same period, EV-D68 was not detected. Phylogenetic analysis revealed that the first Korean EV-D68 belonged to subclade B3. Amino acid sequence alignment of international subclade B3 EV-D68 strains also showed that our strain is genetically more related to those from Europe than those from Japan.</p><p><strong>Conclusion: </strong>We first detected EV-D68 in three Korean children who had EV detected by the Allplex mRT-PCR kit in 2022. EV-D68 also circulated in Korea in fall 2022, but the prevalence and severity seemed to be lower than those in previous reports from other countries.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"422-430"},"PeriodicalIF":4.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10169901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study. 人类免疫缺陷病毒感染急性冠脉综合征患者的死亡率:一项全国性的研究。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-12-01 Epub Date: 2023-11-17 DOI: 10.3947/ic.2023.0050
Hyemin Jung, Eunyoung Lee, Jun-Soo Ro, Jin Yong Lee, Jihwan Bang

Background: There have been few studies on the outcome of acute coronary syndrome (ACS) in human immunodeficiency virus (HIV) infection in the era when antiretroviral therapy (ART) is generalized and most of them have achieved viral suppression. Using claims data, we aimed to assess the mortality after atherosclerotic cardiovascular events in people with HIV (PWH) who maintain optimal adherence to ART.

Materials and methods: We used claims data from the National Health Insurance of the Korea to confirm newly diagnosed PWH from 2009 to 2019, and measured ART adherence. ACS and mortality were confirmed in PWH who showed optimal adherence to ART.

Results: Among 7,100 PWH with optimal adherence and during 27,387 person-year of follow-up duration, ACS was confirmed in 140 (2.0%) cases, which was 1.3 times greater than statistics of the Korean general population (511.0 vs. 383.1 per 100,000). Acquired immunodeficiency syndrome, hypertension, dyslipidemia, and diabetes mellitus were associated with the development of ACS in PWH with optimal adherence. Mortality was confirmed in 10 cases, which is 7.1% overall and 2.9% when limited to myocardial infarction. It was comparable with the mortality rate of the Korean general population after myocardial infarction (8.9%).

Conclusion: ACS prevalence was higher in PWH even when optimal adherence was maintained. However, mortality after ACS was comparable to that in the HIV-negative population.

背景:在抗逆转录病毒治疗(ART)广泛应用的时代,关于人类免疫缺陷病毒(HIV)感染急性冠状动脉综合征(ACS)结局的研究很少,大多数研究都实现了病毒抑制。使用索赔数据,我们旨在评估维持最佳ART依从性的HIV感染者(PWH)动脉粥样硬化性心血管事件后的死亡率。材料和方法:我们使用韩国国民健康保险的索赔数据来确认2009年至2019年新诊断的PWH,并测量抗逆转录病毒治疗的依从性。在坚持抗逆转录病毒治疗的PWH患者中,ACS和死亡率得到了证实。结果:在7100名依从性最佳的PWH患者中,在27387人年的随访时间中,确诊ACS的病例有140例(2.0%),是韩国普通人群统计数据的1.3倍(511.0比383.1 / 10万)。获得性免疫缺陷综合征、高血压、血脂异常和糖尿病与最佳依从性PWH中ACS的发生有关。10例确诊死亡率,总体为7.1%,仅限于心肌梗死时为2.9%。这与韩国普通人群心肌梗死后的死亡率(8.9%)相当。结论:即使维持最佳依从性,PWH患者ACS患病率仍较高。然而,ACS后的死亡率与hiv阴性人群相当。
{"title":"Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study.","authors":"Hyemin Jung, Eunyoung Lee, Jun-Soo Ro, Jin Yong Lee, Jihwan Bang","doi":"10.3947/ic.2023.0050","DOIUrl":"10.3947/ic.2023.0050","url":null,"abstract":"<p><strong>Background: </strong>There have been few studies on the outcome of acute coronary syndrome (ACS) in human immunodeficiency virus (HIV) infection in the era when antiretroviral therapy (ART) is generalized and most of them have achieved viral suppression. Using claims data, we aimed to assess the mortality after atherosclerotic cardiovascular events in people with HIV (PWH) who maintain optimal adherence to ART.</p><p><strong>Materials and methods: </strong>We used claims data from the National Health Insurance of the Korea to confirm newly diagnosed PWH from 2009 to 2019, and measured ART adherence. ACS and mortality were confirmed in PWH who showed optimal adherence to ART.</p><p><strong>Results: </strong>Among 7,100 PWH with optimal adherence and during 27,387 person-year of follow-up duration, ACS was confirmed in 140 (2.0%) cases, which was 1.3 times greater than statistics of the Korean general population (511.0 <i>vs.</i> 383.1 per 100,000). Acquired immunodeficiency syndrome, hypertension, dyslipidemia, and diabetes mellitus were associated with the development of ACS in PWH with optimal adherence. Mortality was confirmed in 10 cases, which is 7.1% overall and 2.9% when limited to myocardial infarction. It was comparable with the mortality rate of the Korean general population after myocardial infarction (8.9%).</p><p><strong>Conclusion: </strong>ACS prevalence was higher in PWH even when optimal adherence was maintained. However, mortality after ACS was comparable to that in the HIV-negative population.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"471-478"},"PeriodicalIF":4.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138447054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Can We Deal with Psychosocial Issues in an Emerging Infectious Disease Outbreak? Lessons from a Qualitative Study for the MERS Outbreak in Korea. 在新出现的传染病疫情中,我们如何应对心理社会问题?韩国MERS疫情定性研究的经验教训。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-09-01 Epub Date: 2023-06-07 DOI: 10.3947/ic.2022.0161
Hye Yoon Park, Haewoo Lee, Ji-Yeon Lee, Kyoung-Ho Song, Yeonjae Kim, So Hee Lee

Background: The 2015 Middle East respiratory syndrome (MERS) coronavirus outbreak in Korea led to profound emotional and social burdens, especially in patients and health care professionals.

Materials and methods: Focus group interviews were conducted with 2 patients, 1 family member and 6 health care professionals about psychological distress related to MERS in 2017 and analyzed the interview data using the consensual qualitative research method.

Results: Four domains and 17 core ideas were identified within three interview groups, including psychological distress during the outbreak, problems regarding the response to the outbreak, positive experiences, and future directions for enhancing intervention to improve mental health and prevent psychosocial problems during the outbreak. Psychological consequences were affected by the characteristics of the emerging infectious disease and the structure and process of institutional or governmental response to the MERS outbreak. Mental health services and psychosocial support reduced the negative impact on psychological distress.

Conclusion: The MERS outbreak in 2015 gave rise to emotional and social injuries to patients and health care professionals, some of which can be long-lasting constraints in their lives. Preparedness in a society's response to a pandemic considering mental health in related parties can minimize negative psychological consequences and enhance resilience at the individual and society levels.

背景:2015年中东呼吸综合征(MERS)冠状病毒在韩国爆发,给患者和医护人员带来了沉重的情感和社会负担。材料和方法:2017年对2名患者、1名家庭成员和6名医护人员进行了关于MERS相关心理困扰的焦点小组访谈,并采用双方同意的定性研究方法对访谈数据进行分析。结果:在三个访谈组中确定了四个领域和17个核心思想,包括疫情期间的心理困扰、应对疫情的问题、积极的经验以及加强干预以改善心理健康和预防疫情期间心理社会问题的未来方向。心理后果受到新发传染病的特点以及机构或政府应对MERS疫情的结构和过程的影响。心理健康服务和心理社会支持减少了对心理困扰的负面影响。结论:2015年爆发的MERS给患者和医护人员带来了情感和社会伤害,其中一些可能是他们生活中的长期制约因素。考虑到相关方的心理健康,社会应对疫情的准备工作可以最大限度地减少负面心理后果,并增强个人和社会层面的韧性。
{"title":"How Can We Deal with Psychosocial Issues in an Emerging Infectious Disease Outbreak? Lessons from a Qualitative Study for the MERS Outbreak in Korea.","authors":"Hye Yoon Park, Haewoo Lee, Ji-Yeon Lee, Kyoung-Ho Song, Yeonjae Kim, So Hee Lee","doi":"10.3947/ic.2022.0161","DOIUrl":"10.3947/ic.2022.0161","url":null,"abstract":"<p><strong>Background: </strong>The 2015 Middle East respiratory syndrome (MERS) coronavirus outbreak in Korea led to profound emotional and social burdens, especially in patients and health care professionals.</p><p><strong>Materials and methods: </strong>Focus group interviews were conducted with 2 patients, 1 family member and 6 health care professionals about psychological distress related to MERS in 2017 and analyzed the interview data using the consensual qualitative research method.</p><p><strong>Results: </strong>Four domains and 17 core ideas were identified within three interview groups, including psychological distress during the outbreak, problems regarding the response to the outbreak, positive experiences, and future directions for enhancing intervention to improve mental health and prevent psychosocial problems during the outbreak. Psychological consequences were affected by the characteristics of the emerging infectious disease and the structure and process of institutional or governmental response to the MERS outbreak. Mental health services and psychosocial support reduced the negative impact on psychological distress.</p><p><strong>Conclusion: </strong>The MERS outbreak in 2015 gave rise to emotional and social injuries to patients and health care professionals, some of which can be long-lasting constraints in their lives. Preparedness in a society's response to a pandemic considering mental health in related parties can minimize negative psychological consequences and enhance resilience at the individual and society levels.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"355-367"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b1/84/ic-55-355.PMC10551710.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10259988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult Immunization Policy in Korea. 韩国的成人免疫政策。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-09-01 DOI: 10.3947/ic.2023.0089
Won Suk Choi

Although adult immunization is different from children's, vaccine preventable diseases (VPDs) for adults are significant in that they are more severe and cause more deaths than VPDs for children. Additionally, the emergence of new vaccines and an increase in the elderly population are increasing demands for policy support for adult vaccination. Accordingly, in this paper, I will look at the characteristics of adult immunization, policies that have been implemented in Korea, and considerations.

尽管成人免疫与儿童免疫不同,但成人疫苗可预防疾病(VPD)的重要意义在于,它们比儿童的VPD更严重,导致更多的死亡。此外,新疫苗的出现和老年人口的增加,增加了对成人疫苗接种政策支持的需求。因此,在本文中,我将研究成人免疫的特点、韩国实施的政策和考虑因素。
{"title":"Adult Immunization Policy in Korea.","authors":"Won Suk Choi","doi":"10.3947/ic.2023.0089","DOIUrl":"10.3947/ic.2023.0089","url":null,"abstract":"<p><p>Although adult immunization is different from children's, vaccine preventable diseases (VPDs) for adults are significant in that they are more severe and cause more deaths than VPDs for children. Additionally, the emergence of new vaccines and an increase in the elderly population are increasing demands for policy support for adult vaccination. Accordingly, in this paper, I will look at the characteristics of adult immunization, policies that have been implemented in Korea, and considerations.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"55 3","pages":"317-321"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/06/1b/ic-55-317.PMC10551718.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41173544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Microbiological Characteristics of Chryseobacterium indologenes Bacteremia: A 20-Year Experience in a Single University Hospital. 吲哚根金杆菌菌血症的临床和微生物学特征:一所大学医院20年的经验。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-09-01 Epub Date: 2023-02-20 DOI: 10.3947/ic.2022.0133
Jeonghyun Chang, Sollip Kim, Yee Gyung Kwak, Tae Hyun Um, Chong Rae Cho, Je Eun Song

Background: Chryseobacterium indologenes is ubiquitous in nature and rarely causes infections. However, the clinical impact of C. indologenes has increased in recent years, especially in immunocompromised patients, and has resulted in high mortality rates. We aimed to investigate the clinical and microbiological characteristics of C. indologenes bacteremia.

Materials and methods: We retrospectively reviewed medical records of a 642-bed university-affiliated hospital in Korea, dating from January 2001 to December 2020, to investigate C. indologenes bacteremia.

Results: A total of 22 C. indologenes isolates were identified from blood culture records. All patients were hospitalized at the time of bacteremia, and the most common manifestation was primary bacteremia. A sizable majority of the patients (83.3%) had underlying diseases, and all patients received intensive care unit care during their admission. The 14-day and 28-day mortality rates were 8.3% and 16.7%, respectively. Importantly, all C. indologenes isolates were 100% susceptible to trimethoprim-sulfamethoxazole.

Conclusion: In our study, most of the infections were hospital-acquired, and the susceptibility pattern of the C. indologenes isolates showed multidrug resistance. However, trimethoprim-sulfamethoxazole is a potentially useful antibiotic for C. indologenes bacteremia treatment. More attention is required to identify C. indologenes as one of the most important nosocomial bacteria with detrimental effects in immunocompromised patients.

背景:吲哚温杆菌在自然界中普遍存在,很少引起感染。然而,近年来吲哚菌的临床影响有所增加,尤其是在免疫功能受损的患者中,并导致了高死亡率。我们旨在研究吲哚菌菌血症的临床和微生物学特征。材料和方法:我们回顾性回顾了2001年1月至2020年12月韩国一所拥有642张床位的大学附属医院的医疗记录,以调查吲哚菌菌血症。结果:从血培养记录中共鉴定出22株吲哚菌。所有患者均在菌血症发生时住院,最常见的表现为原发性菌血症。相当多的患者(83.3%)有潜在疾病,所有患者在入院期间都接受了重症监护室护理。14天和28天的死亡率分别为8.3%和16.7%。重要的是,所有吲哚菌分离株都对甲氧苄啶-硫甲恶唑100%敏感。结论:在我们的研究中,大多数感染是医院获得性的,吲哚菌分离物的易感性模式显示出多药耐药性。然而,甲氧苄啶-磺胺甲恶唑是一种潜在有用的抗生素,可用于吲哚菌菌血症的治疗。需要更多的关注来确定吲哚菌是最重要的医院细菌之一,对免疫功能受损的患者具有有害影响。
{"title":"Clinical and Microbiological Characteristics of <i>Chryseobacterium indologenes</i> Bacteremia: A 20-Year Experience in a Single University Hospital.","authors":"Jeonghyun Chang,&nbsp;Sollip Kim,&nbsp;Yee Gyung Kwak,&nbsp;Tae Hyun Um,&nbsp;Chong Rae Cho,&nbsp;Je Eun Song","doi":"10.3947/ic.2022.0133","DOIUrl":"10.3947/ic.2022.0133","url":null,"abstract":"<p><strong>Background: </strong><i>Chryseobacterium indologenes</i> is ubiquitous in nature and rarely causes infections. However, the clinical impact of <i>C. indologenes</i> has increased in recent years, especially in immunocompromised patients, and has resulted in high mortality rates. We aimed to investigate the clinical and microbiological characteristics of <i>C. indologenes</i> bacteremia.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed medical records of a 642-bed university-affiliated hospital in Korea, dating from January 2001 to December 2020, to investigate <i>C. indologenes</i> bacteremia.</p><p><strong>Results: </strong>A total of 22 <i>C. indologenes</i> isolates were identified from blood culture records. All patients were hospitalized at the time of bacteremia, and the most common manifestation was primary bacteremia. A sizable majority of the patients (83.3%) had underlying diseases, and all patients received intensive care unit care during their admission. The 14-day and 28-day mortality rates were 8.3% and 16.7%, respectively. Importantly, all <i>C. indologenes</i> isolates were 100% susceptible to trimethoprim-sulfamethoxazole.</p><p><strong>Conclusion: </strong>In our study, most of the infections were hospital-acquired, and the susceptibility pattern of the <i>C. indologenes</i> isolates showed multidrug resistance. However, trimethoprim-sulfamethoxazole is a potentially useful antibiotic for <i>C. indologenes</i> bacteremia treatment. More attention is required to identify <i>C. indologenes</i> as one of the most important nosocomial bacteria with detrimental effects in immunocompromised patients.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"322-327"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/69/ic-55-322.PMC10551719.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10824844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Causes of a Low Measles Seroprevalence among Young Healthcare Workers in Korea. 韩国年轻医护人员麻疹血清流行率低的原因。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-09-01 Epub Date: 2023-08-04 DOI: 10.3947/ic.2023.0049
Hyemin Chung, Sung-Kwan Cho, Jiyeon Joo, Sun-Kyung Kim, Eun Ok Kim, Min Jae Kim, Yong Pil Chong, Sang-Ho Choi, Sang-Oh Lee, Yang Soo Kim, Jiwon Jung, Sung-Han Kim

Background: Sporadic measles outbreaks have continued to occur in Korea, mainly in adults in their 20s and 30s, most notably in 2014 and 2019. We here evaluated the possible causes of a low seroprevalance of measles by testing young healthcare workers (HCWs).

Materials and methods: This study was conducted in a 2,743-bed tertiary-care hospital in Seoul between 2020 and 2021. We performed a measles antibody test (chemiluminescence immunoassay), measured the IgM/IgG index ratio, and conducted an avidity test at 1-month after Measles-Mumps-Rubella (MMR) vaccination in HCWs who had been seronegative for measles. Measles vaccination histories were obtained from the national vaccine registry.

Results: Of the 3,173 HCWs newly employed in our hospital during the study period, 54 with a negative measles IgG at commencement were enrolled. Thirty six (67%) of these subjects were female, and the median age was 25 years (interquartile range [IQR]: 24 - 27). Fourty nine (91%) showed seroconversion at 1 month after the first vaccination. Of these individuals, 38 received both measles IgM and IgG test, and all had an IgM/IgG index <1. Of the 49 seroconverters, all HCWs showed a high avidity index. According to the national immunization registry, 45 (83%) received at least 2 doses of an MMR vaccination.

Conclusion: Secondary vaccine failure may underlie vaccine failure in young Korean adults. HCWs born after 1985 with a negative measles antibody may need only a single dose booster vaccination rather than a 2-dose vaccination regimen.

背景:零星的麻疹疫情在韩国持续发生,主要发生在20多岁和30多岁的成年人身上,最显著的是在2014年和2019年。我们通过对年轻医护人员(HCW)的检测,评估了麻疹血清流行率低的可能原因。材料和方法:这项研究于2020年至2021年间在首尔一家拥有2743张床位的三级护理医院进行。我们进行了麻疹抗体测试(化学发光免疫测定),测量了IgM/IgG指数比率,并在麻疹腮腺炎(MMR)疫苗接种后1个月对麻疹血清阴性的HCW进行了亲合力测试。麻疹疫苗接种史从国家疫苗登记处获得。结果:在研究期间,我院新聘用的3173名HCW中,有54名在开始时麻疹IgG呈阴性。其中三十六名(67%)受试者为女性,中位年龄为25岁(四分位间距[IQR]:24-27)。49人(91%)在第一次接种疫苗后1个月出现血清转化。在这些人中,38人同时接受了麻疹IgM和IgG测试,所有人都有IgM/IgG指数。结论:二次疫苗失败可能是韩国年轻成年人疫苗失败的原因。1985年后出生的麻疹抗体呈阴性的HCW可能只需要单剂加强针接种,而不是两剂疫苗接种方案。
{"title":"Causes of a Low Measles Seroprevalence among Young Healthcare Workers in Korea.","authors":"Hyemin Chung,&nbsp;Sung-Kwan Cho,&nbsp;Jiyeon Joo,&nbsp;Sun-Kyung Kim,&nbsp;Eun Ok Kim,&nbsp;Min Jae Kim,&nbsp;Yong Pil Chong,&nbsp;Sang-Ho Choi,&nbsp;Sang-Oh Lee,&nbsp;Yang Soo Kim,&nbsp;Jiwon Jung,&nbsp;Sung-Han Kim","doi":"10.3947/ic.2023.0049","DOIUrl":"10.3947/ic.2023.0049","url":null,"abstract":"<p><strong>Background: </strong>Sporadic measles outbreaks have continued to occur in Korea, mainly in adults in their 20s and 30s, most notably in 2014 and 2019. We here evaluated the possible causes of a low seroprevalance of measles by testing young healthcare workers (HCWs).</p><p><strong>Materials and methods: </strong>This study was conducted in a 2,743-bed tertiary-care hospital in Seoul between 2020 and 2021. We performed a measles antibody test (chemiluminescence immunoassay), measured the IgM/IgG index ratio, and conducted an avidity test at 1-month after Measles-Mumps-Rubella (MMR) vaccination in HCWs who had been seronegative for measles. Measles vaccination histories were obtained from the national vaccine registry.</p><p><strong>Results: </strong>Of the 3,173 HCWs newly employed in our hospital during the study period, 54 with a negative measles IgG at commencement were enrolled. Thirty six (67%) of these subjects were female, and the median age was 25 years (interquartile range [IQR]: 24 - 27). Fourty nine (91%) showed seroconversion at 1 month after the first vaccination. Of these individuals, 38 received both measles IgM and IgG test, and all had an IgM/IgG index <1. Of the 49 seroconverters, all HCWs showed a high avidity index. According to the national immunization registry, 45 (83%) received at least 2 doses of an MMR vaccination.</p><p><strong>Conclusion: </strong>Secondary vaccine failure may underlie vaccine failure in young Korean adults. HCWs born after 1985 with a negative measles antibody may need only a single dose booster vaccination rather than a 2-dose vaccination regimen.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"388-393"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/8f/ic-55-388.PMC10551712.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10169904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnant Women and Their Neonates in Korea. 韩国孕妇及其新生儿严重急性呼吸系统综合征冠状病毒2型感染的临床特征和垂直传播。
IF 4.2 Q2 INFECTIOUS DISEASES Pub Date : 2023-09-01 Epub Date: 2023-06-07 DOI: 10.3947/ic.2022.0077
Jiyoung Lee, Mi-Young Lee, Jina Lee, Euijin Jang, Seongman Bae, Jiwon Jung, Min Jae Kim, Young Pil Chong, Hye-Sung Won, Euiseok Jung, Sung-Han Kim

Background: There are limited data on the clinical characteristics and the vertical transmission rate of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their neonates in Korea.

Materials and methods: Pregnant women who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were retrospectively reviewed in Asan Medical Center from September 1, 2020, to April 26, 2022. All neonates and infected women underwent a polymerase chain reaction test for severe acute respiratory syndrome corona virus 2 within 24 hours of birth and at 48-hour interval if they stayed in the hospital.

Results: A total of 60 pregnant women gave birth by cesarean section (n = 40, 66.7%) or vaginal delivery (n = 20, 33.3%). Among them, 3 women gave birth to twins. Delivery occurred, on average, at 38+2 weeks (± 2+0) of gestational age, and 9 patients (15.0%) had underlying diseases. Of these 60 patients, 9 (15.0%) received coronavirus disease 2019 vaccinations. Pneumonia was confirmed by a chest radiograph in 7 patients (11.7%), and 2 patients (3.3%) required supplemental oxygen therapy, both of whom eventually recovered. The mean birthweight of the neonates was 3,137 g (± 557.6). Further, 8 neonates (12.7%) were of low-birth weight (< 2,500 g), and 11 neonates (17.5%) were preterm (<37 weeks of gestation). Apgar score was median 8 (8 - 9) at 1 minute and 9 (9 - 9.5) at 5 minutes. Four neonates (6.3%) required invasive mechanical ventilation. All neonates had negative SARS-CoV-2 test results. Therefore, there was no vertical transmission in 63 of the neonates (0%, 95% confidence interval [CI]: 0 - 6).

Conclusion: Pregnant Korean women with SARS-CoV-2-infection had favorable obstetric outcomes, and the risk of vertical transmission to their neonates was low. Managing the infection risks of pregnant women and their neonates during the coronavirus disease 2019 pandemic are required.

背景:关于韩国严重急性呼吸综合征冠状病毒2型(严重急性呼吸系统综合征冠状病毒)感染孕妇及其新生儿的临床特征和垂直传播率的数据有限。材料和方法:对2020年9月1日至2022年4月26日在峨山医疗中心检测出严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染呈阳性的孕妇进行回顾性审查。所有新生儿和受感染的妇女在出生后24小时内接受了严重急性呼吸综合征冠状病毒2型聚合酶链式反应检测,如果她们住院,则每隔48小时进行一次。结果:60例孕妇采用剖宫产(n=40,66.7%)或阴道分娩(n=20,33.3%),其中3例产下双胞胎。分娩平均发生在孕龄38+2周(±2+0),9名患者(15.0%)有潜在疾病。在这60名患者中,9人(15.0%)接种了2019冠状病毒病疫苗。7名患者(11.7%)的胸部X线片证实了肺炎,2名患者(3.3%)需要补充氧气治疗,两人最终都康复了。新生儿平均出生体重3137g(±557.6),低出生体重儿8例(12.7%),11名新生儿(17.5%)早产(结论:感染严重急性呼吸系统综合征冠状病毒2型的韩国孕妇有良好的产科结局,垂直传播给新生儿的风险较低。需要在2019冠状病毒病大流行期间管理孕妇及其新生儿的感染风险。
{"title":"Clinical Characteristics and Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnant Women and Their Neonates in Korea.","authors":"Jiyoung Lee,&nbsp;Mi-Young Lee,&nbsp;Jina Lee,&nbsp;Euijin Jang,&nbsp;Seongman Bae,&nbsp;Jiwon Jung,&nbsp;Min Jae Kim,&nbsp;Young Pil Chong,&nbsp;Hye-Sung Won,&nbsp;Euiseok Jung,&nbsp;Sung-Han Kim","doi":"10.3947/ic.2022.0077","DOIUrl":"10.3947/ic.2022.0077","url":null,"abstract":"<p><strong>Background: </strong>There are limited data on the clinical characteristics and the vertical transmission rate of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their neonates in Korea.</p><p><strong>Materials and methods: </strong>Pregnant women who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were retrospectively reviewed in Asan Medical Center from September 1, 2020, to April 26, 2022. All neonates and infected women underwent a polymerase chain reaction test for severe acute respiratory syndrome corona virus 2 within 24 hours of birth and at 48-hour interval if they stayed in the hospital.</p><p><strong>Results: </strong>A total of 60 pregnant women gave birth by cesarean section (n = 40, 66.7%) or vaginal delivery (n = 20, 33.3%). Among them, 3 women gave birth to twins. Delivery occurred, on average, at 38<sup>+2</sup> weeks (± 2<sup>+0</sup>) of gestational age, and 9 patients (15.0%) had underlying diseases. Of these 60 patients, 9 (15.0%) received coronavirus disease 2019 vaccinations. Pneumonia was confirmed by a chest radiograph in 7 patients (11.7%), and 2 patients (3.3%) required supplemental oxygen therapy, both of whom eventually recovered. The mean birthweight of the neonates was 3,137 g (± 557.6). Further, 8 neonates (12.7%) were of low-birth weight (< 2,500 g), and 11 neonates (17.5%) were preterm (<37 weeks of gestation). Apgar score was median 8 (8 - 9) at 1 minute and 9 (9 - 9.5) at 5 minutes. Four neonates (6.3%) required invasive mechanical ventilation. All neonates had negative SARS-CoV-2 test results. Therefore, there was no vertical transmission in 63 of the neonates (0%, 95% confidence interval [CI]: 0 - 6).</p><p><strong>Conclusion: </strong>Pregnant Korean women with SARS-CoV-2-infection had favorable obstetric outcomes, and the risk of vertical transmission to their neonates was low. Managing the infection risks of pregnant women and their neonates during the coronavirus disease 2019 pandemic are required.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"346-354"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/e2/ic-55-346.PMC10551714.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10259993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Infection and Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1